10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-021906`
Period End Date	20220930
Filing Date	20221103
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	alhc-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 72 Cash Flow Statement 94 Stockholders Equity 34

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$111.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$217.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$567.45M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`Cash`	$466.60M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $217 at September 30, 2022 and $111 at December 31, 2021, respectively)	`AccountsReceivableNetCurrent`	$88.22M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $217 at September 30, 2022 and $111 at December 31, 2021, respectively)	`AccountsReceivableNetCurrent`	$58.51M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$27.75M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$36.49M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$552.86M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$692.16M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$35.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.36M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$6.08M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.26M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$7.85M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.19M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$37.62M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.26M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.12M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.71M	USD	Point-in-time
Total assets	`Assets`	$630.89M	USD	Point-in-time
Total assets	`Assets`	$777.54M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$125.89M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$171.40M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$16.96M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$20.69M	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$469.00K	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$116.77M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$31.41M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$23.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$167.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$340.26M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$150.62M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$160.68M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$4.46M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$6.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$324.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$505.40M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2022 and December 31, 2021 respectively; no shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2022 and December 31, 2021 respectively; no shares issued and outstanding as of September 30, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 187,263,976 and 187,193,613 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 187,263,976 and 187,193,613 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$947.29M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$888.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-675.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-582.69M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$272.14M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$306.04M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$777.54M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$630.89M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$293.27M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$869.01M	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$1.07B	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$359.98M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$898.00K	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$191.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$370.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$485.00K	USD	3 Qtrs
Total revenues	`Revenues`	$360.35M	USD	1 Quarter
Total revenues	`Revenues`	$293.47M	USD	1 Quarter
Total revenues	`Revenues`	$1.07B	USD	3 Qtrs
Total revenues	`Revenues`	$869.50M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$923.88M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$779.47M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$253.99M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$312.85M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$212.42M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$76.45M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$212.91M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$76.85M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.08M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.72M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.59M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.46M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.15B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$393.76M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.00B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$334.92M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-134.61M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-76.53M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-41.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-33.41M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.61M	USD	1 Quarter
Interest expense	`InterestExpense`	$13.50M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.41M	USD	1 Quarter
Interest expense	`InterestExpense`	$12.99M	USD	3 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-131.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-48.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$252.00K	USD	3 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-145.00K	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-15.94M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-6.67M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-12.85M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.37M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-45.82M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-92.48M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-147.45M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.08M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$167.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$167.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-92.64M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-40.25M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	182.12M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	177.83M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	180.77M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	169.79M	shares	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.51	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.87	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.51	USD	3 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.87	USD	3 Qtrs

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-147.45M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-92.64M	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$74.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$39.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$150.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Loss on sublease	`LossOnSublease`	$510.00K	USD	3 Qtrs
Loss on sublease	`LossOnSublease`	-	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$11.88M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$12.73M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.61M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.68M	USD	3 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	$3.12M	USD	3 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	$2.94M	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$81.79M	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$58.83M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$2.00M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$2.15M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-2.20M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$29.84M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.73M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.74M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$11.83M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$137.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$45.51M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$15.40M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.03M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-539.00K	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$116.30M	USD	3 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$96.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.48M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$4.64M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.13M	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.78M	USD	3 Qtrs
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	-	USD	3 Qtrs
Payment-in-kind interest	`IncreaseDecreaseInDebtInstrumentPaymentInKindInterestOnPrincipalBalance`	$-14.12M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.64M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$103.84M	USD	3 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	3 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$2.39M	USD	3 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.41M	USD	3 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$2.48M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$2.83M	USD	3 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$2.42M	USD	3 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.43M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-17.32M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.41M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.11M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.86M	USD	3 Qtrs
Repurchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$15.00K	USD	3 Qtrs
Repurchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$-100.00K	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	3 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$165.00M	USD	3 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$4.60M	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	3 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$143.18M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.12M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$100.85M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$293.62M	USD	3 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.19M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$22.45M	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$438.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$290.00K	USD	3 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$375.00K	USD	3 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	3 Qtrs
Cash	`CashAndCashEquivalentsAtCarryingValue`	$567.45M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$500.49M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$950.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$569.20M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.26M	shares	Point-in-time
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-92.64M	USD	3 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-40.25M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$1.04M	USD	Point-in-time
Issuance of common stock, net of issuance costs, Shares	`StockIssuedDuringPeriodSharesNewIssues`	9.20M	shares	Point-in-time
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	3 Qtrs
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.51M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$63.80M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$58.83M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.69M	USD	1 Quarter
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	3 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-100.00K	USD	3 Qtrs
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$272.14M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.26M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.